Vulnerability

Vulnerability describes the constellation of biological, psychological, and situational factors that shift a person's likelihood of harm from a given exposure relative to the general population. Age, organ function, psychiatric and cardiac history, genetics, isolation, and setting each contribute. It names a position relative to a risk, not a fixed trait.

Most population-level risk estimates assume an average person in average conditions. When a person's profile differs substantially from that average — in ways that compound rather than cancel — standard precautions calibrated to the average may be insufficient.

How it is done

Assessing vulnerability involves reviewing factors known to alter how a substance acts, or how a person responds to its effects. Hepatic function shapes clearance speed; reduced function prolongs and intensifies exposure. Age affects sensitivity at both ends — adolescent neural development and physiological changes in older age alter pharmacodynamic response in distinct ways.

A personal or family history of psychosis, cardiac arrhythmia, or seizure disorder marks mechanistic pathways where risk is elevated for specific substance classes. Genetic variation in drug-metabolising enzymes — particularly the CYP450 family — can make a person a slow or fast metaboliser, altering effective exposure without any change in what was taken. These variants are usually unknown unless specifically tested.

Setting and situation compound biological factors. Using alone, in an unfamiliar environment, or during a period of acute psychological stress reduces the margin for an adverse response to be caught and managed before it progresses.

What it cannot tell you

Identifying no obvious vulnerabilities does not establish safety — it establishes that the known elevation is absent. Idiosyncratic reactions, undiagnosed conditions, and unanticipated substance combinations sit outside what any pre-assessment of prior factors can reach.

The most consequential form of this limit is the undetected vulnerability: the cardiac condition that has caused no symptoms, the genetic variant that has never been clinically relevant, the psychological fragility that presents as composure. A person with none of the standard markers can experience a severe adverse event; a person with several may not. Population distributions are real; they do not predict individual outcomes.

Setting vulnerabilities are particularly susceptible to rapid change. An environment assessed as safe earlier in the day may have shifted; the presence of trusted people at the outset of an experience does not guarantee their presence or capacity throughout it.

Vulnerability assessment also cannot substitute for substance-specific precautions. Knowing that one metabolises compounds slowly does not determine how to approach a particular substance on a particular occasion — that depends on the compound's pharmacokinetic profile, the route of administration, and the person's current physiological and psychological state.